COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 18 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $50,935 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 577,909 | $4,056,921 | 9.19% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 463,899 | $3,256,571 | 0.62% |
| VILLERE ST DENIS J & CO LLC | 289,797 | $2,034,374 | 0.15% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 65,911 | $463 | 0.02% |
| Shay Capital LLC | 10,000 | $70,200 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 13,202 | $92,678 | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,120 | $162,302 | 0.00% |
| BROWN ADVISORY INC | 73,849 | $518,420 | 0.00% |
| Geneos Wealth Management Inc. | 750 | $5,265 | 0.00% |
| Focused Wealth Management, Inc | 242 | $1,699 | 0.00% |